Novo Nordisk A/S ADR (NVO)

$162.97 0.53 (0.33%)

19:00 EDT NVO Stock Quote Delayed 30 Minutes

3 Biotech Stocks With Blockbuster Potential

By Josh Enomoto, InvestorPlace Contributor May 24, 2023

Although risky, these biotech stocks with blockbuster potential may skyrocket should regulatory winds favor their therapeutics.

7 Top Growth Stocks to Buy for the Next Decade

7 Healthcare Stocks That Will Be Big Winners in 2023

3 Global Stocks to Buy to Get Around America’s Slowdown

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 963,081

Day's Range $162.75 - $164.68

52-Week Range $95.02 - $172.97

Dividend & Yield N/A (N/A)

NVO Stock Predictions, Articles, and Novo Nordisk A/S ADR News

From InvestorPlace
From the Web

7 Hot Stocks to Book Profits In Before 2023

By Josh Enomoto, InvestorPlace Contributor Dec 19, 2022

With major macroeconomic headwinds appearing on the horizon, it’s time for investors to consider the hot stocks to book profits in.

Our 7 Top Biotech Stock Picks for 2023

By Josh Enomoto, InvestorPlace Contributor Dec 9, 2022

Following the devastation of Covid-19, there’s greater interest toward medical innovations, thus bolstering biotech stock picks for 2023.

Forma Therapeutics (FMTX) Stock Soars on Novo Nordisk Acquisition News

By David Moadel, InvestorPlace Contributor Sep 1, 2022

There's a major pharmaceutical market deal afoot -- and it's worth over $1 billion -- so FMTX stock is heading higher on the news.

3 Stocks to Buy Before the Housing Market Crashes

By Alex Sirois Aug 26, 2022

Economists' expectations of a housing market crash are rising, making these potentially stocks stronger choices in the aftermath.

7 Long-Term Stocks to Buy Before the Bull Market Returns

By Muslim Farooque, InvestorPlace Contributor Aug 7, 2022

For massive future returns, consider taking a position in these long-term stocks to buy before the bull market returns.

ESG Investing: 7 Profitable Stock Picks for the Socially Responsible

By Tezcan Gecgil, InvestorPlace Contributor Jun 24, 2022

ESG investing has not been immune to declines in the current bear market

The 7 Best Long-Term Stocks to Buy and Hold Until 2032

By Ian Bezek, InvestorPlace Contributor May 26, 2022

Markets are shaky right now. But these seven best long-term stocks to buy and hold should work in just about any economic environment.

7 Pharmaceutical Stocks Working on Their Next Blockbuster

By Alex Sirois Mar 12, 2021

Pharmaceutical stocks are a sector with unique success factors. One factor is developing blockbuster drugs. These 7 are close.

7 Safe Stocks to Buy for Solid Returns in Tumultuous Times

By Ian Bezek, InvestorPlace Contributor Jan 28, 2021

While stocks keep going up and up, more risks are mounting under the surface. As such, you should be looking at safe stocks to buy now.

7 Cheap Stocks to Buy for 2021 That Deserve Recognition

By Alex Sirois Dec 3, 2020

These 7 cheap stocks span industry and have a great chance to appreciate in price next year. Click here for the metrics and reasoning.

Hold Novo Nordisk Shares for Consistent International Growth

By Louis Navellier and the InvestorPlace Research Staff Sep 30, 2020

The company's value chain may have been shaken by Covid-19 but it wasn't broken, so Novo Nordisk stock holders should stay invested.

The Top 7 Healthcare Stocks You Should Be Watching

By Ian Bezek, InvestorPlace Contributor Sep 9, 2020

The healthcare industry has historically delivered market-beating returns. And the current pandemic has created new opportunities in the sector.

The 7 Best Pharmaceutical Stocks That Go Beyond the Covid-19 Chase

By Louis Navellier and the InvestorPlace Research Staff Jul 14, 2020

There’s a select group of pharmaceutical stocks that stand to win without even looking for a Covid-19 cure.

7 Healthcare Stocks Worth Your Time Now

By Louis Navellier, Editor, Growth Investor Mar 9, 2020

These healthcare stocks have great financials now, and in the future. They all represent the future of medicine, and offer big growth.

10 Dividend Stocks to Buy That Are Off to a Fast Start in 2020

By Will Ashworth, InvestorPlace Contributor Feb 21, 2020

What’s left after the sale are the Norton and LifeLock consumer cybersafety brands. On its first day of trading, UBS analyst Fatima Boolani gave NLOK stock a buy rating and a $27 target price. Boolani believes that NLOK has an excellent chance to be a strong generator of free cash flow and providing investors with a healthy dividend.

Novo Nordisk A/S ADR (NVO)

3 Biotech Stocks With Blockbuster Potential

7 Top Growth Stocks to Buy for the Next Decade

7 Healthcare Stocks That Will Be Big Winners in 2023

3 Global Stocks to Buy to Get Around America’s Slowdown

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Novo Nordisk A/S ADR (NVO)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

NVO Stock Predictions, Articles, and Novo Nordisk A/S ADR News

Subscriber Sign in